Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-17-019329

Options or other derivatives

  • Director acquired 30,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Erck Stanley C · Director

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2017-05-24 Grant or award : show line 1 in the form Automatic Stock Option Grant +30,000 $5.13 2027-05-24 30,000 30,000 D
Loading xslF345X03/form4.xml…